Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2024-05-06 00:00:00 ET · period of report 2024-05-03 · accession 0001883850-24-000020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-06 | 2024-05-03 | REGN | SING GEORGE L | Dir | F - Tax | $942.53 | -877 | 27.5K | -3% | -$826.6K |
| D | 2024-05-06 | 2024-05-03 | REGN | SING GEORGE L | Dir | M - OptEx | $413.33 | +2,000 | 28.3K | +8% | +$826.7K |
| D | 2024-05-06 | 2024-05-03 | REGN | SING GEORGE L | Dir | M - OptEx | $0.00 | -2,000 | 3,338 | -37% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-03 | F | D | 877 | $942.53 | 27,472 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-03 | M | A | 2,000 | $413.33 | 28,349 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-05-03 | M | D | 2,000 | $0.00 | 3,338 | D | $413.33 · — to 2025-01-02 | 2,000 Common Stock | (F1) The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. |